Highly Selective Escape from KSHV-mediated Host mRNA Shutoff and Its Implications for Viral Pathogenesis
暂无分享,去创建一个
[1] B. Roizman,et al. The herpes simplex virus 1 UL41 gene-dependent destabilization of cellular RNAs is selective and may be sequence-specific. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[2] D. Ganem,et al. Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. , 2004, Molecular cell.
[3] D. Ganem,et al. Host Range of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Cells , 2003, Journal of Virology.
[4] W. Kaelin,et al. HIF hydroxylation and the mammalian oxygen-sensing pathway. , 2003, The Journal of clinical investigation.
[5] P. Pellett,et al. Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus , 2003, AIDS.
[6] P. Moore,et al. Viral IL-6-Induced Cell Proliferation and Immune Evasion of Interferon Activity , 2002, Science.
[7] Julia T. Chu,et al. Rta of the human herpesvirus 8/Kaposi sarcoma-associated herpesvirus up-regulates human interleukin-6 gene expression. , 2002, Blood.
[8] J. Derisi,et al. Modulation of host gene expression by the constitutively active G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus. , 2002, Cancer research.
[9] C. Boshoff,et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. , 2002, Blood.
[10] R. Leurs,et al. Kaposi's Sarcoma-Associated Herpesvirus-Encoded G Protein-Coupled Receptor ORF74 Constitutively Activates p44/p42 MAPK and Akt via Gi and Phospholipase C-Dependent Signaling Pathways , 2002, Journal of Virology.
[11] T. Tlsty,et al. Induction of tubulogenesis in telomerase-immortalized human microvascular endothelial cells by glioblastoma cells. , 2002, Experimental cell research.
[12] A. Blauvelt,et al. Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. , 2001, Blood.
[13] E. Brown,et al. Quantitative analysis of mRNA amplification by in vitro transcription. , 2001, Nucleic acids research.
[14] D. Ganem,et al. Transcriptional Activation by the Product of Open Reading Frame 50 of Kaposi’s Sarcoma-Associated Herpesvirus Is Required for Lytic Viral Reactivation in B Cells , 1999, Journal of Virology.
[15] A. Haase,et al. Expression of the Open Reading Frame 74 (G-Protein-Coupled Receptor) Gene of Kaposi’s Sarcoma (KS)-Associated Herpesvirus: Implications for KS Pathogenesis , 1999, Journal of Virology.
[16] E. van Marck,et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[17] N. Kamada,et al. Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells. , 1998, Blood.
[18] E. Cesarman,et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.
[19] M. Corbellino,et al. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. , 1997, The American journal of pathology.
[20] A. Waggoner,et al. Stability, specificity and fluorescence brightness of multiply-labeled fluorescent DNA probes. , 1997, Nucleic acids research.
[21] E. Cesarman,et al. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation , 1997, Nature.
[22] A. Haase,et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells , 1997, Journal of virology.
[23] E. Cesarman,et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.
[24] D. Ganem,et al. The biology of Kaposi's sarcoma. , 2001, Cancer treatment and research.